Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADALIMUMAB for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 56,634 adverse event reports in the FDA FAERS database where ADALIMUMAB was used for Psoriasis.

Most Reported Side Effects for ADALIMUMAB

Side Effect Reports % Deaths Hosp.
Drug ineffective 71,926 14.4% 1,675 11,783
Pain 37,514 7.5% 2,020 9,822
Arthralgia 35,592 7.1% 1,893 8,782
Rheumatoid arthritis 29,817 6.0% 2,076 6,523
Fatigue 29,420 5.9% 2,196 7,284
Injection site pain 28,679 5.7% 43 1,849
Headache 19,891 4.0% 1,906 5,361
Nausea 19,299 3.9% 1,450 6,570
Rash 18,690 3.7% 1,953 4,915
Pain in extremity 18,319 3.7% 1,156 4,915
Joint swelling 18,266 3.7% 2,037 5,007
Diarrhoea 18,120 3.6% 1,815 7,132
Device issue 17,630 3.5% 19 1,191
Psoriasis 16,698 3.3% 555 3,143
Off label use 16,417 3.3% 2,187 5,051

Other Indications for ADALIMUMAB

Rheumatoid arthritis (154,287) Crohn's disease (99,540) Product used for unknown indication (63,549) Psoriatic arthropathy (47,183) Colitis ulcerative (34,530) Ankylosing spondylitis (25,131) Hidradenitis (18,344) Uveitis (5,600) Juvenile idiopathic arthritis (4,658) Arthritis (1,380)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628) HUMIRA (6,346)

Related Pages

ADALIMUMAB Full Profile All Psoriasis Drugs ADALIMUMAB Demographics ADALIMUMAB Timeline